Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.19)
# 3,490
Out of 4,868 analysts
510
Total ratings
30.72%
Success rate
-15.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Maintains: Buy | $145 → $138 | $106.53 | +29.54% | 42 | Jun 16, 2025 | |
| EXEL Exelixis | Maintains: Buy | $40 → $47 | $40.37 | +16.42% | 8 | Jun 12, 2025 | |
| IMMX Immix Biopharma | Reiterates: Buy | $7 | $2.24 | +212.50% | 8 | Jun 4, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $14 → $12 | $7.23 | +65.98% | 11 | May 20, 2025 | |
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $12 → $11 | $4.41 | +149.43% | 21 | May 19, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Buy | $44 → $41 | $9.32 | +339.91% | 4 | May 16, 2025 | |
| HURA TuHURA Biosciences | Reiterates: Buy | $12 | $2.56 | +368.75% | 3 | May 16, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $39 → $40 | $21.30 | +87.79% | 4 | May 15, 2025 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $39 → $40 | $25.22 | +58.60% | 9 | May 14, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $73 → $72 | $39.66 | +81.54% | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $9.31 | +136.31% | 24 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $3.10 | +480.65% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.88 | +467.54% | 16 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $74 → $47 | $46.96 | +0.09% | 32 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $1.34 | +123.88% | 14 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.16 | +151.94% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $11.48 | +213.59% | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $8.05 | +24.22% | 7 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.77 | +188.81% | 21 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.46 | +189.02% | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.31 | +52.67% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.08 | +362.96% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.23 | +550.41% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $12 | $2.33 | +415.02% | 13 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $2.37 | +1,337.63% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $13 | $12.47 | +4.25% | 20 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.97 | +407.61% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.41 | +254.61% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.19 | +401.57% | 21 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $9.27 | +137.32% | 16 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.27 | - | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.86 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.17 | +840.17% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $0.88 | +155.68% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $5.70 | +3,411.85% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $0.28 | +7,030.12% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.54 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $3.03 | +4,850.50% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.36 | +1,517.65% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.19 | +488.24% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $2.32 | +374.14% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $0.10 | +224,900.00% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $3.89 | +542.67% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $2.05 | +534.15% | 1 | Jan 7, 2021 |
BioNTech SE
Jun 16, 2025
Maintains: Buy
Price Target: $145 → $138
Current: $106.53
Upside: +29.54%
Exelixis
Jun 12, 2025
Maintains: Buy
Price Target: $40 → $47
Current: $40.37
Upside: +16.42%
Immix Biopharma
Jun 4, 2025
Reiterates: Buy
Price Target: $7
Current: $2.24
Upside: +212.50%
Cogent Biosciences
May 20, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $7.23
Upside: +65.98%
Y-mAbs Therapeutics
May 19, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $4.41
Upside: +149.43%
Bicara Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $44 → $41
Current: $9.32
Upside: +339.91%
TuHURA Biosciences
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $2.56
Upside: +368.75%
Enliven Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $21.30
Upside: +87.79%
ArriVent BioPharma
May 14, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $25.22
Upside: +58.60%
Revolution Medicines
May 14, 2025
Maintains: Buy
Price Target: $73 → $72
Current: $39.66
Upside: +81.54%
May 9, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $9.31
Upside: +136.31%
May 9, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $3.10
Upside: +480.65%
May 5, 2025
Reiterates: Buy
Price Target: $5
Current: $0.88
Upside: +467.54%
Apr 30, 2025
Downgrades: Neutral
Price Target: $74 → $47
Current: $46.96
Upside: +0.09%
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $1.34
Upside: +123.88%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $5.16
Upside: +151.94%
Apr 2, 2025
Reiterates: Buy
Price Target: $36
Current: $11.48
Upside: +213.59%
Apr 2, 2025
Reiterates: Buy
Price Target: $10
Current: $8.05
Upside: +24.22%
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $2.77
Upside: +188.81%
Mar 31, 2025
Reiterates: Buy
Price Target: $10
Current: $3.46
Upside: +189.02%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.31
Upside: +52.67%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.08
Upside: +362.96%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.23
Upside: +550.41%
Mar 18, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $2.33
Upside: +415.02%
Mar 18, 2025
Maintains: Buy
Price Target: $40 → $34
Current: $2.37
Upside: +1,337.63%
Mar 10, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $12.47
Upside: +4.25%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.97
Upside: +407.61%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.41
Upside: +254.61%
Mar 7, 2025
Reiterates: Buy
Price Target: $16
Current: $3.19
Upside: +401.57%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $9.27
Upside: +137.32%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.27
Upside: -
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.86
Upside: -
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.17
Upside: +840.17%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $0.88
Upside: +155.68%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $5.70
Upside: +3,411.85%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $0.28
Upside: +7,030.12%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.54
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $3.03
Upside: +4,850.50%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.36
Upside: +1,517.65%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.19
Upside: +488.24%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $2.32
Upside: +374.14%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $0.10
Upside: +224,900.00%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $3.89
Upside: +542.67%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $2.05
Upside: +534.15%